FindTrial
Sign In

Comparison of effect between bupivacaine and ropivacaine in hypertensive pregnant women undergoing LSCS under spinal

A comparative study of efficacy of spinal anaesthesia with hyperbaric bupivacaine 0.5% and hyperbaric ropivacaine 0.75% in patients with hypertensive disorders of pregnancy undergoing emergency LSCS :A randomised controlled trail - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/12/060916
Enrollment
100
Registered
2023-12-28
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O100- Pre-existing essential hypertension complicating pregnancy, childbirth and the puerperium

Interventions

Intervention1: Comparison of efficacy of hyperbaric bupivacaine & hyperbaric ropivacain: hyperbaric ropivacain All patients meeting inclusion criteria will be taken for ot where randomised person will

Sponsors

Vijayanagar institute of medical sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient belonging to ASA 2-3 under going emergency LSCS with preeclampsia or chronic hypertension Gestational age 37weeks to 42 weeks

Exclusion criteria

Exclusion criteria: Reffusal Allergy to above drugs Contraindications to spinal anaesthesia Morbid obesity

Design outcomes

Primary

MeasureTime frame
To compare haemodynamic stability of intrathecal hyperbaric bupivacaine 0.5% versus hyperbaric ropivacaine 0.75% in terms of total dose inj phenylephrine required intraoperativelyTimepoint: To compare haemodynamic stability of intrathecal hyperbaric bupivacaine 0.5% versus hyperbaric ropivacaine 0.75% in terms of total dose inj phenylephrine required intraoperatively—

Secondary

MeasureTime frame
Onset of sensory & motor blockade, duration of sensory and motor blockade, pain using NES score, any adverse reactionsTimepoint: Above said parameters are checked every 5 min until procedure finished—

Countries

India

Contacts

Public ContactDR BALASUBRAMANYAH

Vijayanagar institute of medical sciences

halsanadu@gmail.com9980600724

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026